Convexity Labs

MEOH

Convexity Analyst · MEOH
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: Methanex Corporation (MEOH)

Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

  • Conservative Entry: $42.93
  • Breakout Level: $42.93 (Conservative Entry)
  • Current Price: $53.18
  • Extension: +23.9% above the conservative entry.
  • Volatility Context: The ATR at the time of breakout was 2.7% (productive), indicating a structural quality entry. Current ATR is 4.4% (high), reflecting elevated volatility in the current trading environment.

2. Thesis Layer

As of this date, MEOH is a TACTICAL, setup-led name. There is no named secular thesis attached to this specific setup in the current data layer. The conviction for this position must be derived strictly from the quality of the technical structure (the confirmed coil) and the immediate business fundamentals provided in the evidence base, rather than a long-term macro narrative. The setup suggests a cyclical recovery in pricing, but the primary driver for the current trade is the structural breakout and the management's guidance on near-term pricing and volume.

3. Business Overview

Methanex Corporation is a primary worldwide supplier of methanol, established in 1968 and headquartered in Vancouver, Canada. The company operates a vertically integrated model, manufacturing methanol across North America, the Asia Pacific, Europe, and South America, while also acquiring product from external producers via long-term contracts and spot market deals to serve its customer base in the chemical and petrochemical sectors. To support these global operations, the company owns and leases storage and terminal facilities and oversees a fleet of roughly 30 ocean-going ships.

Key Operational & Financial Data (as of April 30, 2026 Earnings):

  • Pricing Environment: Management estimates average realized prices for April and May at $500 to $525 per tonne, based on contract price postings.
  • EBITDA Outlook: Assuming pricing holds through June and volumes remain consistent with Q1, management expects a significant increase in adjusted EBITDA for the second quarter.
  • Production Guidance: Equity production for 2026 is maintained at 9 million tonnes.
  • Operational Adjustments: A Chile plant is expected to be idled during the middle of the second quarter due to gas availability constraints associated with the Southern Hemisphere winter season.
  • Supply Dynamics: The Middle East, a major global supplier, has significantly reduced its methanol supply to global markets (approx. 20 million tonnes annually) since the beginning of March, creating a supply tightness context.
  • Balance Sheet Action: Management expects to repay a term loan of approximately $290 million in the second quarter.

4. Archetype and Conviction

Archetype: Cyclical Recovery The setup fits the Cyclical Recovery archetype, driven by the sharp improvement in realized methanol prices ($500–$525/tonne) and the supply constraints in the Middle East. The business is currently benefiting from a pricing inflection that management explicitly links to a "significant increase" in Q2 EBITDA.

Valuation & Financial Spine: The financial spine indicates a forward consensus EPS of $8.915 for FY1 and $5.519 for FY2. This suggests a market expectation of strong earnings in the current fiscal year, followed by a normalization or decline in the subsequent year, consistent with a cyclical peak or recovery phase.

Conviction Stack:

  • Thesis Strength: Moderate. The thesis is tactical and setup-driven, lacking a long-term secular narrative, but is supported by strong near-term pricing data.
  • Evidence Quality: High. The evidence is derived from primary earnings transcripts and financial spine data, providing concrete figures on pricing, volume, and balance sheet deleveraging.
  • Structural Quality: High. The ATR at breakout (2.7%) was in the "productive" range, and the current price extension (+23.9%) indicates strong momentum without immediate exhaustion signals (though current ATR is high).
  • Rerating Potential: Moderate. The rerating is contingent on the realization of the Q2 EBITDA increase and the successful repayment of the $290M debt, which improves the balance sheet.

5. Invalidations, Strengtheners, and Gaps

Invalidation:

  • A significant deviation from the $500–$525/tonne pricing assumption in June, or a failure to achieve the "significant increase" in EBITDA as guided, would weaken the fundamental thesis.
  • Unexpected operational disruptions beyond the planned Chile plant idling.

Strengtheners:

  • Confirmation that June contract postings remain at or above the $525/tonne level.
  • Successful execution of the $290M debt repayment in Q2.
  • Sustained supply reductions from Middle East producers.

Gaps in Evidence:

  • Missing Evidence: There is no specific data on the *exact* Q1 2026 EBITDA figure to compare against the projected Q2 increase, nor is there a detailed breakdown of the "produced sales volumes" mentioned in the guidance.
  • Missing Evidence: No specific data on the *current* inventory levels or the specific impact of the Chile plant idling on total 2026 production volume beyond the 9 million tonne guidance.
  • Missing Evidence: No explicit guidance on capital expenditure (Capex) for the remainder of 2026 or 2027, which is relevant for a cyclical recovery assessment.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed active coil with price +23.9% above entry; Management guidance of $500-$525/tonne realized prices for April/May; Expectation of significant Q2 EBITDA increase and $290M debt repayment. Key risks: High current ATR (4.4%) indicating elevated volatility; Planned idling of Chile plant in Q2; Cyclical nature of methanol pricing could reverse if Middle East supply returns; FY2 EPS consensus decline. Sizing hint: Standard position sizing for a confirmed active setup; reduce size if ATR expands further above 5%. Expected horizon: 3 to 6 months (through Q2 earnings release and debt repayment completion).

Loading chart...
Exhibit 1: MEOH daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for MEOH.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for MEOH.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: